12 results on '"Yamauchi, Nobuhiko"'
Search Results
2. Feasibility and clinical utility of comprehensive genomic profiling of hematological malignancies.
- Author
-
Fukuhara, Suguru, Oshikawa‐Kumade, Yuji, Kogure, Yasunori, Shingaki, Sumito, Kariyazono, Hirokazu, Kikukawa, Yoshiya, Koya, Junji, Saito, Yuki, Tabata, Mariko, Yoshifuji, Kota, Mizuno, Kota, Miyagi‐Maeshima, Akiko, Matsushita, Hiromichi, Sugiyama, Masanaka, Ogawa, Chitose, Inamoto, Yoshihiro, Fukuda, Takahiro, Sugano, Masato, Yamauchi, Nobuhiko, and Minami, Yosuke
- Abstract
Identification of genetic alterations through next‐generation sequencing (NGS) can guide treatment decision‐making by providing information on diagnosis, therapy selection, and prognostic stratification in patients with hematological malignancies. Although the utility of NGS‐based genomic profiling assays was investigated in hematological malignancies, no assays sufficiently cover driver mutations, including recently discovered ones, as well as fusions and/or pathogenic germline variants. To address these issues, here we have devised an integrated DNA/RNA profiling assay to detect various types of somatic alterations and germline variants at once. Particularly, our assay can successfully identify copy number alterations and structural variations, including immunoglobulin heavy chain translocations, IKZF1 intragenic deletions, and rare fusions. Using this assay, we conducted a prospective study to investigate the feasibility and clinical usefulness of comprehensive genomic profiling for 452 recurrently altered genes in hematological malignancies. In total, 176 patients (with 188 specimens) were analyzed, in which at least one alteration was detected in 171 (97%) patients, with a median number of total alterations of 7 (0–55). Among them, 145 (82%), 86 (49%), and 102 (58%) patients harbored at least one clinically relevant alteration for diagnosis, treatment, and prognosis, respectively. The proportion of patients with clinically relevant alterations was the highest in acute myeloid leukemia, whereas this assay was less informative in T/natural killer‐cell lymphoma. These results suggest the clinical utility of NGS‐based genomic profiling, particularly for their diagnosis and prognostic prediction, thereby highlighting the promise of precision medicine in hematological malignancies. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
3. PB2317: POLATUZUMAB VEDOTIN PLUS BENDAMUSTINE AND RITUXIMAB THERAPY IN RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA: A SINGLE‐INSTITUTION EXPERIENCE FOCUSING ON DETAILED ASSESSMENT OF TOXICITIES.
- Author
-
Hirano, Mitsuhito, Yoshida, Kikuaki, Hirano, Kei, Teramoto, Yukako, Tamba, Mikako, Yamauchi, Nobuhiko, Shirouchi, Yuko, Ishihara, Yuko, Asai, Hiroaki, Mishima, Yuko, Takeuchi, Kengo, and Maruyama, Dai
- Published
- 2023
- Full Text
- View/download PDF
4. Prophylactic antiviral therapy for hepatitis B virus surface antigen‐positive patients with diffuse large B‐cell lymphoma treated with rituximab‐containing chemotherapy.
- Author
-
Yamauchi, Nobuhiko, Maruyama, Dai, Choi, Ilseung, Atsuta, Yoshiko, Sakai, Rika, Miyashita, Kazuho, Moriuchi, Yukiyoshi, Tsujimura, Hideki, Kubota, Nobuko, Yamamoto, Go, Igarashi, Tadahiko, Izutsu, Koji, Yoshida, Shinichiro, Kojima, Kensuke, Uchida, Toshiki, Inoue, Yoshiko, Tsukamoto, Norifumi, Ohtsuka, Eiichi, Suzuki, Sachiko, and Inaguma, Yoko
- Abstract
We conducted a nationwide retrospective analysis of 116 hepatitis B virus (HBV) surface antigen (HBsAg)‐positive patients with diffuse large B‐cell lymphoma (DLBCL) and 278 HBsAg‐negative patients with DLBCL, as a control cohort, who received rituximab‐containing regimens as an induction chemotherapy at 30 Japanese medical centers between January 2004 and December 2014. Hepatitis was defined as an absolute serum alanine aminotransferase (ALT) level of ≥100 U/L. HBV reactivation‐related hepatitis was defined as hepatitis with an absolute serum HBV DNA level of ≥3.3 log IU/mL or an absolute increase of ≥2 log compared with the baseline value. HBsAg‐positive patients were divided into three groups based on anti–HBV prophylactic therapy: no nucleos(t)ide analogue (non–NA, n = 9), lamivudine (LAM, n = 20), and entecavir (ETV, n = 87). The 4‐year cumulative incidence (CI) of hepatitis in HBsAg‐positive and HBsAg‐negative patients was 21.1% and 14.6% (P =.081), respectively. The 4‐year CI of HBV reactivation‐related hepatitis was higher in HBsAg‐positive patients than in HBsAg‐negative patients (8.0% vs 0.4%; P <.001). Among HBsAg‐positive patients, the 4‐year CI of HBV reactivation‐related hepatitis was the highest in the non–NA group (33.3%), followed by the LAM (15.0%) and ETV (3.8%) groups (P <.001). Of note, 3 non–NA patients (33%) and 1 LAM patient (5%) (but no ETV patients) died due to HBV hepatitis. Based on Cox multivariate analysis, HBsAg positivity was not associated with poor overall survival. Prophylactic use of ETV would reduce the occurrence of HBV reactivation‐related hepatitis and mortality in HBsAg‐positive DLBCL patients receiving rituximab‐containing chemotherapy. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
5. Conserved Roles of Fibroblast Growth Factor Receptor 2 Signaling in the Regulation of Inner Cell Mass Development in Bovine Blastocysts
- Author
-
Akizawa, Hiroki, Nagatomo, Hiroaki, Odagiri, Haruka, Kohri, Nanami, Yamauchi, Nobuhiko, Yanagawa, Yojiro, Nagano, Masashi, Takahashi, Masashi, and Kawahara, Manabu
- Subjects
blastocyst ,bovine ,inner cell mass ,cell-lineage specification ,fibroblast growth factor signaling - Abstract
A common process during preimplantation mammalian development is blastocyst formation, which utilizes signaling through fibroblast growth factor receptor 2 (FGFR2), yet the mechanisms through which FGFR2 signaling affect preimplantation development in bovine embryos remain incompletely understood. Here, we used RNA-interference to investigate the in vitro development, the frequency of blastomere apoptosis, and the mRNA expression of developmental marker genes in FGF receptor 2-knockdown (FGFR2-KD) bovine embryos. A reduction in FGFR2 mRNA did not affect preimplantation development or the frequency of apoptotic blastomeres, but did enhanced proliferation of the inner cell mass in blastocysts (P< 0.05) -which differs from the phenotype reported for bovine embryos using a pharmacological approach (treatment with the pan-FGFR blocker PD173074), but agrees with previous results obtained using mouse embryos. Moreover, the expression of an epiblast marker gene, NANOG, and a primitive endoderm marker gene, GATA6, remained unchanged, whereas the expression of another primitive endoderm marker gene, HNF4A, was significantly reduced in FGFR2-KD embryos. Therefore, FGFR2 signaling appears to be associated with the regulation of inner cell mass development and proliferation during blastocyst formation in cattle.
- Published
- 2016
6. Requirement for nuclear autoantigenic sperm protein mRNA expression in bovine preimplantation development
- Author
-
Nagatomo, Hiroaki, Kohri, Nanami, Akizawa, Hiroki, Hoshino, Yumi, Yamauchi, Nobuhiko, Kono, Tomohiro, Takahashi, Masashi, and Kawahara, Manabu
- Subjects
knockdown ,bovine embryo ,NASP - Abstract
Nuclear autoantigenic sperm protein (NASP) is associated with DNA replication, cell proliferation, and cell cycle progression through its specific binding to histones. The aim of this study was to examine the roles of NASP in bovine preimplantation embryonic development. Using NASP gene knockdown (KD), we confirmed the reduction of NASP messenger RNA (mRNA) expression during preimplantation development. NASP KD did not affect cleavage but significantly decreased development of embryos into the blastocyst stage. Furthermore, blastocyst hatching was significantly decreased in NASP KD embryos. Cell numbers in the inner cell mass of NASP KD blastocysts were also decreased compared to those of controls. These results suggest that NASP mRNA expression is required for preimplantation development into the blastocyst stage in cattle.
- Published
- 2016
7. Transformation Scoring System (TSS): A new assessment index for clinical transformation of follicular lymphoma.
- Author
-
Shichijo, Takafumi, Maruyama, Dai, Yamauchi, Nobuhiko, Maeshima, Akiko Miyagi, Sugano, Masato, Yuda, Sayako, Tajima, Kinuko, Kurihara, Hiroaki, Shimada, Kaoru, Suzuki, Tomotaka, Toyoda, Kosuke, Makita, Shinichi, Fukuhara, Suguru, Munakata, Wataru, Suzuki, Tatsuya, Kobayashi, Yukio, Taniguchi, Hirokazu, Minami, Yosuke, Izutsu, Koji, and Tobinai, Kensei
- Subjects
LYMPHOMAS ,PUBLIC hospitals ,LACTATE dehydrogenase ,AGROBACTERIUM tumefaciens ,RITUXIMAB ,CANCER hospitals ,FOLLICULAR lymphoma - Abstract
Although histologic analysis is the gold standard for diagnosing follicular lymphoma (FL) transformation, many patients are diagnosed with transformation by clinical factors as biopsy specimens often cannot be obtained. Despite the frequency of clinical diagnosis, no clinical assessment tool has yet been established for FL transformation in the rituximab era. We derived and validated a transformation scoring system (TSS) based on retrospective analyses of 126 patients with biopsy‐proven FL and histologic transformation (HT) at two hospitals of the National Cancer Center of Japan. In the derivation set (76 patients), the detailed analyses of the clinical characteristics at disease progression showed that lactate dehydrogenase (LDH) elevation, focal lymph nodal (LN) enlargement, hemoglobin <12 g/dl, and poor performance status (PS) (2‐4) were associated with HT. The weights of these variables were decided based on the regression coefficients. Next, we constructed a TSS encompassing the above four factors: LDH, (> upper limit of normal [ULN], ≤ULN ×2) (1 point), (≥ULN ×2) (2 points); focal LN enlargement, (≥3 cm, <7 cm) (1 point), (≥7 cm) (2 points); hemoglobin <12 g/dl (1 point); poor PS (2 points). We identified a high positive predictive value (PPV) (96.4%) and negative predictive value (NPV) (85.4%) for diagnosing HT when a cutoff score of 2 was selected for our TSS. In an external validation set (50 patients), the probability of HT was high with scores ≥2 (PPV, 93.3%; NPV, 82.9%). We developed a TSS that offers a simple, yet, valuable tool, for diagnosing HT, especially in patients who cannot undergo biopsy. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
8. R‐CHOP‐14 versus R‐CHOP‐14/CHASER for upfront autologous transplantation in diffuse large B‐cell lymphoma: JCOG0908 study.
- Author
-
Kagami, Yoshitoyo, Yamamoto, Kazuhito, Shibata, Taro, Tobinai, Kensei, Imaizumi, Yoshitaka, Uchida, Toshiki, Shimada, Kazuyuki, Minauchi, Koichiro, Fukuhara, Noriko, Kobayashi, Hirofumi, Yamauchi, Nobuhiko, Tsujimura, Hideki, Hangaishi, Akira, Tominaga, Ryo, Suehiro, Youko, Yoshida, Shinichiro, Inoue, Yoshiko, Suzuki, Sachiko, Tokuhira, Michihide, and Kusumoto, Shigeru
- Abstract
The efficiency of upfront consolidation with high‐dose chemotherapy/autologous stem‐cell transplantation (HDCT/ASCT) for newly diagnosed high‐risk diffuse large B‐cell lymphoma (DLBCL) may be influenced by induction chemotherapy. To select better induction chemotherapy regimens for HDCT/ASCT, a randomized phase II study was conducted in high‐risk DLBCL patients having an age‐adjusted International Prognostic Index (aaIPI) score of 2 or 3. As induction chemotherapy, 6 cycles of R‐CHOP‐14 (arm A) or 3 cycles of R‐CHOP‐14 followed by 3 cycles of CHASER (arm B) were planned, and patients who responded proceeded to HDCT with LEED and ASCT. The primary endpoint was 2‐y progression‐free survival (PFS), and the main secondary endpoints included overall survival, overall response rate, and adverse events (AEs). In total, 71 patients were enrolled. With a median follow‐up of 40.3 mo, 2‐y PFS in arms A and B were 68.6% (95% confidence interval [CI], 50.5%‐81.2%) and 66.7% (95% CI: 48.8%‐79.5%), respectively. Overall survival at 2 y in arms A and B was 74.3% (95% CI: 56.4%‐85.7%) and 83.3% (95% CI: 66.6%‐92.1%). Overall response rates were 82.9% in arm A and 69.4% in arm B. During induction chemotherapy, 45.7% and 75.0% of patients in arms A and B, respectively, had grade ≥ 3 non‐hematologic toxicities. One patient in arm A and 6 in arm B discontinued induction chemotherapy due to AEs. In conclusion, R‐CHOP‐14 showed higher 2‐y PFS and less toxicity compared with R‐CHOP‐14/CHASER in patients with high‐risk DLBCL, suggesting the former to be a more promising induction regimen for further investigations (UMIN‐CTR, UMIN000003823). [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
9. P1106: CLINICAL OUTCOME OF PATIENTS WITH LOCALIZED PRIMARY GASTRIC MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA: LONG-TERM FOLLOW-UP RESULTS FROM A SINGLE-INSTITUTION OBSERVATIONAL STUDY.
- Author
-
Hirano, Kei, Yoshida, Kikuaki, Inoue, Norihito, Tsuyama, Naoko, Teramoto, Yukako, Hirano, Mitsuhito, Tanba, Mikako, Yamauchi, Nobuhiko, Shirouchi, Yuko, Ishihara, Yuko, Asai, Hiroaki, Mishima, Yuko, Taguchi, Senzo, Hirasawa, Toshiaki, Takeuchi, Kengo, and Maruyama, Dai
- Published
- 2023
- Full Text
- View/download PDF
10. Analysis of differentially expressed genes and the promoters in bovine endometrium throughout estrus cycle and early pregnancy.
- Author
-
Musavi, Sayed A.A., Yamashita, Seiya, Fujihara, Taisuke, Masaka, Hironori, Islam, Md. Rashedul, Kim, Sangwan, Gotoh, Takafumi, Kawahara, Manabu, Tashiro, Kosuke, and Yamauchi, Nobuhiko
- Subjects
GENE expression ,ESTRUS ,SEXUAL cycle ,PREGNANCY in animals ,ENDOMETRIUM ,TRANSCRIPTION factors ,CATTLE - Abstract
Endometrial gene expression is primarily regulated by the ovarian steroids and pregnancy recognition factors. This study was aimed to characterize differential expression genes (DEGs) in bovine endometrium together with the analysis of their promoter region. Bovine uteri at follicular stage (FS), luteal stage (LS), and implantation stage (IS) at Day 18 of pregnancy were collected. Total RNA extracted and prepared cDNA were then subjected to high‐throughput sequencing. For promoter analysis, 1 kb upstream promoter region of each DEG was analyzed. The numbers of highly expressed DEGs were 496 and 597 at FS and LS, respectively. When compared the gene expression of IS with LS, 383 and 346 DEGs showed higher and lower expression at IS, respectively. It was also observed that 20–30 transcription factors (TFs) were included in each DEGs. In addition, promoter analyses estimated 150–160 TFs for each stage. DLX4 and interferon regulatory factor 4 (IRF4) at FS, and IRF5, IRF9, STAT1, and STAT2 at IS were in common to DEGs and estimated TFs, respectively. This study highlighted potential molecular mechanisms controlling endometrial function during estrus cycle and IS, which will further guide to better understand the endometrial functions in future studies. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
11. The nuclear receptor REV- ERB α represses the transcription of growth/differentiation factor 10 and 15 genes in rat endometrium stromal cells.
- Author
-
Zhao, Lijia, Isayama, Keishiro, Chen, Huatao, Yamauchi, Nobuhiko, Shigeyoshi, Yasufumi, Hashimoto, Seiichi, and Hattori, Masa‐aki
- Subjects
NUCLEAR receptors (Biochemistry) ,GROWTH factors ,GENE expression ,BIOLUMINESCENCE ,STROMAL cells - Abstract
Cellular oscillators in the uterus play critical roles in the gestation processes of mammals through entraining of the clock proteins to numerous downstream genes, including growth/differentiation factor ( Gdf) 10 and Gdf15. The expression of Gdf10 and Gdf15 is significantly increased in the uterus during decidualization, but the mechanism underlying the regulation of Gdf gene expression in the uterus is poorly understood. Here, we focused on the function of the cellular oscillators in the expression of Gdf family by using uterine endometrial stromal cells ( UESCs) isolated from pregnant Per2- dLuc transgenic rats. A significant decline of Per2- dLuc bioluminescence activity was induced in in vitro decidualized UESCs, and concomitantly the expression of canonical clock genes was downregulated. Conversely, the expression of Gdf10 and Gdf15 of the Gdf was upregulated. In UESCs transfected with Bmal1-specific si RNA, in which Rev-erbα expression was downregulated, Gdf10 and Gdf15 were upregulated. However, Gdf5, Gdf7, and Gdf11 were not significantly affected by Bmal1 silencing. The expression of Gdf10 and Gdf15 was enhanced after treatment with a REV- ERB α antagonist in the presence or absence of progesterone. Chromatin immunoprecipitation- PCR analysis revealed the inhibitory effect of REV- ERB α on the expression of Gdf10 and Gdf15 in UESCs by recognizing their gene promoters. Collectively, our findings indicate that the attenuation of REV- ERB α leads to an upregulation of Gdf10 and Gdf15 in decidual cells, in which cellular oscillators are impaired. Our results provide novel evidence regarding the functions of cellular oscillators regulating the expression of downstream genes during the differentiation of UESCs. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
12. Effect of organic and inorganic selenium supplementation on semen quality and blood enzymes in buffalo bulls.
- Author
-
El‐Sharawy, Mohamed, Eid, Entsar, Darwish, Samy, Abdel‐Razek, Ibrahim, Islam, Md. Rashedul, Kubota, Kaiyu, Yamauchi, Nobuhiko, and El‐Shamaa, Ibrahim
- Subjects
SELENIUM supplements ,BULLS ,SEMEN analysis ,BLOOD enzymes ,ALANINE aminotransferase - Abstract
The present study aimed to evaluate the effect of organic and inorganic selenium (Se) supplementation on semen quality and blood serum profiles of buffalo bulls. Nine mature buffalo bulls were divided into three groups: control (non-supplemented); organic Se (10 mg Sel-Plex®/head twice weekly) and inorganic Se (10 mg sodium selenite/head twice weekly). Semen was collected twice a week for 3 months during Se supplementation. Semen properties were evaluated from fresh ejaculate. Moreover, fructose concentration, aspartate and alanine transaminase (AST and ALT) activities, total protein and total cholesterol were assayed in seminal plasma. Additionally AST, ALT, testosterone and Se levels were determined in the blood serum. Results showed that Se supplementation significantly ( P < 0.05) influences the semen parameters during 3 months of treatment. Organic Se significantly ( P < 0.05) increased the percentage of viable sperms compared to inorganic Se and the control group. Fructose concentration was significantly higher ( P < 0.05) in the seminal plasma of organic Se-treated bulls. Serum testosterone and Se concentrations were significantly ( P < 0.05) increased in the Se supplemented groups than the control group. In conclusion, Se supplementation improved the parameters of buffalo bull semen and more precisely, organic Se was more effective for the improvement of semen quality and some blood components than inorganic Se. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.